Cerebrospinal Fluid Leak

3

Review clinical trials related to Cerebrospinal Fluid Leak. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Immiseal™ Dural Sealant Post-Market Registry Study

This is a multicentre, prospective, open-label, single-arm, observational, post-market clinical follow-up registry study designed to observe the safety and performance of the Immiseal™ Dural Sealant System when used as an adjunct to standard methods of dural repair to provide watertight closure during neurosurgical procedures. Eligible adult subjects requiring dural repair after neurosurgical procedures or traumatic injury, for whom the investigator has made the clinical decision to use the device, will be enrolled and followed for approximately 100 ± 10 days after surgery.

Participants needed: 85
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Medprin Regenerative Medical Technologies Co., Ltd.Updated: Jun 16, 2026Locations: 1
Eligibility criteria

Age 18 to 75 years old, regardless of gender. [+3]

Immiseal™ Dural Sealant System is not to be used in confined bone structures whe... [+3]

Status: Not yet recruiting

Safety and Efficacy Evaluation of ArtiFix® Sealant Graft in Subjects Requiring Dural Repair Following Neurosurgery

The purpose of this clinical study is to evaluate and establish the safety and efficacy of the ArtiFix® device in subjects scheduled for cranial or spinal surgery that requires Dural repair (membrane that covers the brain and spinal cord). The investigated device will be implanted during the neurosurgical procedure and participants will be evaluated at 30, 120 and 330 days after the procedure.

Participants needed: 20
Trial details
Age: 22-65Biological sex: AllType: InterventionalSponsor: Nurami Medical LtdUpdated: Aug 14, 2025
Eligibility criteria

Subject between the ages of 22-65 (inclusive) [+4]

Subject has known hydrocephalus. [+19]

Status: Not yet recruiting

Effect of Spinal Needle Type on Optic Nerve Sheath Diameter

The optic nerve sheath is a continuation of the dura mater, extending along the subarachnoid space surrounding the optic nerve. Consequently, changes in intracranial pressure cause an augmentation or contraction in the diameter of the optic nerve sheath, which is coreleted with intracranial pressure. Participants undergoing lower extremity operations (ankle, distal tibia and fibula surgeries) using a tourniquet under spinal anesthesia will be investigated. Spinal anesthesia will be performed with a 25 G Whitacre, 25 G Quincke, or 27 G Quincke needle, depending on the study group. Optic nerve sheath diameter (ONSD) measurements will be performed before spinal anesthesia; and 5 minutes, 15 minutes,,24 hours after spinal block, respectively.The 4th measurement will be performed after tourniquet is opened. Measurements will be done with 15 MHz linear ultrasound (US) probe in B mode, 3 mm behind the posterior globe in the transverse plane from both eyes, on upper eyelid. Values will be recorded numerically. The impact of spinal anesthesia administered using various needle designs (Quincke and Whitacre) and sizes (25G-27G) on intracranial pressure will be investigated.

Participants needed: 165
Trial details
Age: 18-40Biological sex: AllType: InterventionalSponsor: Bagcilar Training and Research HospitalUpdated: Jul 30, 2024Locations: 1
Eligibility criteria

American Society of Anesthesiologists (ASA) I-II Risk Classification [+3]

Bilateral tourniquet usage [+10]